"You are Always a Student, Never a Master: You Have to Keep Moving Forward" Conrad Hall
Am J Rhinol Allergy. 2023 Nov;37(6):621-622. doi: 10.1177/19458924231201523.NO ABSTRACTPMID:37786363 | DOI:10.1177/19458924231201523 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - October 3, 2023 Category: ENT & OMF Authors: Anthony Del Signore Source Type: research

Intra Nasal Use of Ethylene Diamine Tetra Acetic Acid for Improving Olfactory Dysfunction Post COVID-19
CONCLUSION: Ethylene diamine tetra acetic acid may be associated with an improvement of the olfactory function post-COVID-19.PMID:37786364 | PMC:PMC10293862 | DOI:10.1177/19458924231184055 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - October 3, 2023 Category: ENT & OMF Authors: Mohamed H Abdelazim Zeyad Mandour Ahmed H Abdelazim Wael F Ismaiel Mohammed Gamal Mohammed A S Abourehab Saleh Alghamdi Mohamed A Alghamdi Rehab R Alrugi Rawan R Alharthi Source Type: research

"You are Always a Student, Never a Master: You Have to Keep Moving Forward" Conrad Hall
Am J Rhinol Allergy. 2023 Nov;37(6):621-622. doi: 10.1177/19458924231201523.NO ABSTRACTPMID:37786363 | DOI:10.1177/19458924231201523 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - October 3, 2023 Category: ENT & OMF Authors: Anthony Del Signore Source Type: research

Intra Nasal Use of Ethylene Diamine Tetra Acetic Acid for Improving Olfactory Dysfunction Post COVID-19
CONCLUSION: Ethylene diamine tetra acetic acid may be associated with an improvement of the olfactory function post-COVID-19.PMID:37786364 | PMC:PMC10293862 | DOI:10.1177/19458924231184055 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - October 3, 2023 Category: ENT & OMF Authors: Mohamed H Abdelazim Zeyad Mandour Ahmed H Abdelazim Wael F Ismaiel Mohammed Gamal Mohammed A S Abourehab Saleh Alghamdi Mohamed A Alghamdi Rehab R Alrugi Rawan R Alharthi Source Type: research

"You are Always a Student, Never a Master: You Have to Keep Moving Forward" Conrad Hall
Am J Rhinol Allergy. 2023 Nov;37(6):621-622. doi: 10.1177/19458924231201523.NO ABSTRACTPMID:37786363 | DOI:10.1177/19458924231201523 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - October 3, 2023 Category: ENT & OMF Authors: Anthony Del Signore Source Type: research

Intra Nasal Use of Ethylene Diamine Tetra Acetic Acid for Improving Olfactory Dysfunction Post COVID-19
CONCLUSION: Ethylene diamine tetra acetic acid may be associated with an improvement of the olfactory function post-COVID-19.PMID:37786364 | DOI:10.1177/19458924231184055 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - October 3, 2023 Category: ENT & OMF Authors: Mohamed H Abdelazim Zeyad Mandour Ahmed H Abdelazim Wael F Ismaiel Mohammed Gamal Mohammed A S Abourehab Saleh Alghamdi Mohamed A Alghamdi Rehab R Alrugi Rawan R Alharthi Source Type: research

Long-Term Efficacy of Dupilumab for Eosinophilic Chronic Rhinosinusitis
CONCLUSION: The NPS remained improved, and the CT score showed further improvement with long-term treatment, whereas olfactory function and olfactory cleft opacification showed significant improvement only after long-term treatment. There was a dissociation between the time to improve in the NPS and CT scores and the time to improve in olfactory function and olfactory cleft opacification. Based on these results, dupilumab should be administered for longer than 1 year, especially for olfactory function.PMID:37750177 | DOI:10.1177/19458924231204128 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - September 26, 2023 Category: ENT & OMF Authors: Yasuhiro Tsunemi Tsuguhisa Nakayama Takashi Kashiwagi Makoto Akutsu Shota Saito Shinichi Haruna Source Type: research

Long-Term Efficacy of Dupilumab for Eosinophilic Chronic Rhinosinusitis
CONCLUSION: The NPS remained improved, and the CT score showed further improvement with long-term treatment, whereas olfactory function and olfactory cleft opacification showed significant improvement only after long-term treatment. There was a dissociation between the time to improve in the NPS and CT scores and the time to improve in olfactory function and olfactory cleft opacification. Based on these results, dupilumab should be administered for longer than 1 year, especially for olfactory function.PMID:37750177 | DOI:10.1177/19458924231204128 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - September 26, 2023 Category: ENT & OMF Authors: Yasuhiro Tsunemi Tsuguhisa Nakayama Takashi Kashiwagi Makoto Akutsu Shota Saito Shinichi Haruna Source Type: research

Long-Term Efficacy of Dupilumab for Eosinophilic Chronic Rhinosinusitis
CONCLUSION: The NPS remained improved, and the CT score showed further improvement with long-term treatment, whereas olfactory function and olfactory cleft opacification showed significant improvement only after long-term treatment. There was a dissociation between the time to improve in the NPS and CT scores and the time to improve in olfactory function and olfactory cleft opacification. Based on these results, dupilumab should be administered for longer than 1 year, especially for olfactory function.PMID:37750177 | DOI:10.1177/19458924231204128 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - September 26, 2023 Category: ENT & OMF Authors: Yasuhiro Tsunemi Tsuguhisa Nakayama Takashi Kashiwagi Makoto Akutsu Shota Saito Shinichi Haruna Source Type: research

Long-Term Efficacy of Dupilumab for Eosinophilic Chronic Rhinosinusitis
CONCLUSION: The NPS remained improved, and the CT score showed further improvement with long-term treatment, whereas olfactory function and olfactory cleft opacification showed significant improvement only after long-term treatment. There was a dissociation between the time to improve in the NPS and CT scores and the time to improve in olfactory function and olfactory cleft opacification. Based on these results, dupilumab should be administered for longer than 1 year, especially for olfactory function.PMID:37750177 | DOI:10.1177/19458924231204128 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - September 26, 2023 Category: ENT & OMF Authors: Yasuhiro Tsunemi Tsuguhisa Nakayama Takashi Kashiwagi Makoto Akutsu Shota Saito Shinichi Haruna Source Type: research

Long-Term Efficacy of Dupilumab for Eosinophilic Chronic Rhinosinusitis
CONCLUSION: The NPS remained improved, and the CT score showed further improvement with long-term treatment, whereas olfactory function and olfactory cleft opacification showed significant improvement only after long-term treatment. There was a dissociation between the time to improve in the NPS and CT scores and the time to improve in olfactory function and olfactory cleft opacification. Based on these results, dupilumab should be administered for longer than 1 year, especially for olfactory function.PMID:37750177 | DOI:10.1177/19458924231204128 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - September 26, 2023 Category: ENT & OMF Authors: Yasuhiro Tsunemi Tsuguhisa Nakayama Takashi Kashiwagi Makoto Akutsu Shota Saito Shinichi Haruna Source Type: research

Long-Term Efficacy of Dupilumab for Eosinophilic Chronic Rhinosinusitis
CONCLUSION: The NPS remained improved, and the CT score showed further improvement with long-term treatment, whereas olfactory function and olfactory cleft opacification showed significant improvement only after long-term treatment. There was a dissociation between the time to improve in the NPS and CT scores and the time to improve in olfactory function and olfactory cleft opacification. Based on these results, dupilumab should be administered for longer than 1 year, especially for olfactory function.PMID:37750177 | DOI:10.1177/19458924231204128 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - September 26, 2023 Category: ENT & OMF Authors: Yasuhiro Tsunemi Tsuguhisa Nakayama Takashi Kashiwagi Makoto Akutsu Shota Saito Shinichi Haruna Source Type: research

Eustachian Tube Balloon Dilation: A Comprehensive Analysis of Adverse Events
CONCLUSION: Though ETBD is generally seen as a safe procedure, there have been several concerning AEs reported to date. Increased awareness of ETBD complications can serve as a primer for improved patient education and counseling during the informed consent process and aid surgeons in clinical decision-making. Future studies with standardized reporting protocols are warranted to create a central registry for ETBD.PMID:37635415 | DOI:10.1177/19458924231193520 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - August 28, 2023 Category: ENT & OMF Authors: Tyler B Merrill Vijay A Patel Christopher Pool John L Dornhoffer Robert A Saadi Source Type: research

Eustachian Tube Balloon Dilation: A Comprehensive Analysis of Adverse Events
CONCLUSION: Though ETBD is generally seen as a safe procedure, there have been several concerning AEs reported to date. Increased awareness of ETBD complications can serve as a primer for improved patient education and counseling during the informed consent process and aid surgeons in clinical decision-making. Future studies with standardized reporting protocols are warranted to create a central registry for ETBD.PMID:37635415 | DOI:10.1177/19458924231193520 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - August 28, 2023 Category: ENT & OMF Authors: Tyler B Merrill Vijay A Patel Christopher Pool John L Dornhoffer Robert A Saadi Source Type: research

Eustachian Tube Balloon Dilation: A Comprehensive Analysis of Adverse Events
CONCLUSION: Though ETBD is generally seen as a safe procedure, there have been several concerning AEs reported to date. Increased awareness of ETBD complications can serve as a primer for improved patient education and counseling during the informed consent process and aid surgeons in clinical decision-making. Future studies with standardized reporting protocols are warranted to create a central registry for ETBD.PMID:37635415 | DOI:10.1177/19458924231193520 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - August 28, 2023 Category: ENT & OMF Authors: Tyler B Merrill Vijay A Patel Christopher Pool John L Dornhoffer Robert A Saadi Source Type: research